T he concept of "united airway disease" relates to the frequent co-occurrence of allergic rhinitis and asthma and best explains how the continuity of the respiratory mucosa from the tip of the nose to the terminal alveolus fashions this concurrence of disease expression. Khan 1 leads off this issue of the Proceedings with an insightful review that reveals how the important relationships between epidemiology and shared pathophysiology common to upper and lower airways affect the clinical expression of allergic disease. Primary prevention of allergic diseases such as atopic dermatitis and asthma is another important area that illustrates the importance of concurrence clinical allergic diseases. In this issue Stelmach et al, 2 utilizing the Polish Mother and Child Cohort Study database, provide practical advice regarding modifiable risk factors associated with the development of atopic dermatitis and early wheeze. Because of the significant clinical implications associated with identification of modifiable risk factors, the article of Stelmach et al is featured in this issue's "For the Patient" section. This segment, found in the back of the print version of this issue and also available online, consists of a one page synopsis of a selected article, that is written in a readily comprehensible fashion to help patients better understand the content of the full article and its diagnostic and therapeutic implications. It is printed in a format to allow reproduction on the practitioner's letterhead for distribution to patients.
In addition to identification of risk factors, when asthma does develop, the challenge of disease management is directed to the achievement of improved asthma control. Within this issue are three articles which focus on the important subject of asthma control. In an exclusive online article, Kraj et al, 3 provide novel insight regarding L-arginine metabolism in children with controlled asthma. Metabolic alterations of L-arginine were found to have important clinical implications and the potential to lead to airway hyperresponsiveness, inflammation and airway remodeling. Poorly controlled asthma associated with frequent exacerbations was found to be associated with airway remodeling and persistent airflow obstruction. In another exclusive online article, Ciebiada et al, 4 examine risk factors for the development of persistent airflow obstruction in nonsmoking adult patients with severe asthma. Their findings may help to predict which patients with asthma are at risk for developing fixed airflow limitation. Another inadequately studied area of asthma control is the association of psychological asthma triggers with asthma symptoms and lung function. Ritz et al, 5 provide novel insight regarding the role of psychological triggers as indicators of patients' perceptions of suboptimal asthma control. Connecting back to the theme of "united airway disease" and further examining the relationship of stress and disease, Tomljenovic et al, 6 provide new data demonstrating an association between patients' perceived stress and severity of chronic rhinosinusitis in allergic and nonallergic rhinitis.
Previous issues of the Proceedings have addressed the great burden of disease and barriers to treatment associated with angioedema. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Directly relating to these issues, three articles appear within the pages of this issue that focus on this heterogeneous disease. [17] [18] [19] In the first article, Felder et al, 17 investigate the emergency department presentation patterns of undifferentiated angioedema at two tertiary care hospitals over a three year period. In their report, they provide clinically useful predictive prognostic markers of disease susceptibility showing a relationship between hospital admission and length of emergency department stay. In the second angioedema article, Lumry et al, 18 reveal the quality of life changes which occur in hereditary angioedema patients in association with the administration of nanofiltered C1 inhibitor (human) for the routine prevention of attacks. In the third angioedema article, Maurer et al, 19 perform a posthoc analysis on the treatment of hereditary angioedema with icatibant, comparing the efficacy of this pharmaceutical agent in clinical trial with its use in a real-world setting. Their findings provide useful insights regarding clinically important outcomes such as time to treatment administration and duration of attack.
Because of the importance of measurement of serum tryptase as a marker for systemic anaphylaxis and mast cell activation disorders, the determination of normal levels of serum basal tryptase is essential. Although the normal range has been well established for adults, data in children is more limited. Shahiner et al, 20 add to our knowledge in this area by assessing serum basal tryptase levels in 113 healthy nonallergic children and correlating their findings with gender and age.
Although growing evidence suggests a strong association of eosinophilic esophagitis (EoE) with atopic disorders, it is not known whether atopic features vary Allergy and Asthma Proceedingsby age. In a study conducted by Vernon et al, 21 a retrospective analysis of demographic and clinical data from 50 children and 50 adults with the diagnosis of EoE provide novel information regarding EoE patient characteristics, history of atopic diseases and allergic sensitizations.
Rounding out the issue is the most recent installment of the Patient-Oriented Problem Solving "POPS" series, which, as per tradition, is written by an allergyimmunology fellow-in-training from one of the 73 US allergy-immunology training programs. The purpose of the POPS series is to provide an innovative and practical learning experience for the allergist-immunologist using a format of clinical presentation, physical findings, appropriate laboratory studies, and differential diagnosis. Kennedy et al, 22 lead the reader through this process, describing the evaluation of a 55-year-old male presenting with onychodystrophy of the toenails and fingernails and recurrent oral-esophageal candidiasis. This case illustrates the complexity of the differential diagnosis for recurrent yeast infections and the importance of a detailed immune assessment.
In summary, the collection of articles found within the pages of this issue provides another insight into important allergic, cutaneous and respiratory disorders afflicting patients whom the allergist-immunologist serves. In keeping with the overall mission of the Proceedings, which is to distribute timely information regarding advancements in the knowledge and practice of allergy, asthma, and immunology to clinicians entrusted with the care of patients, it is our hope that the articles found within this issue achieve this goal and will help foster enhanced patient management through efficient workup and optimal therapy for a great diversity of clinical problems. On behalf of the editorial board, we hope you will enjoy the diversity of literature offered in this issue of the Proceedings. 
